Schroeder Kate A, Witts Benjamin N, Traub Michele R
Community Psychology, Counseling, and Family, St. Cloud State University, St. Cloud, Minnesota, USA.
Int J Dev Disabil. 2021 Mar 9;68(6):984-989. doi: 10.1080/20473869.2021.1895698. eCollection 2022.
Phelan-McDermid syndrome (PMS), also called 22q13.3 deletion syndrome, is a rare genetic disorder affecting at least 2,000 people worldwide (Phelan-McDermid Syndrome Foundation, 2019, How rare is Phelan-McDermid?). PMS has many distinguishing characteristics and many medical specialties have been recommended to treat the clinical features. While many therapies, including behavioral therapy, have been speculated to be beneficial in treating PMS, there is little known regarding their effectiveness [Costales, J. L. and Kolevzon, A. 2015. Phelan-McDermid syndrome and SHANK3: Implications for treatment. Neurotherapeutics: The Journal of the American Society for Experimental Neurotherapeutics, 12, 620-630.]. Behavior analysis has the capability to help in many areas of treatment for PMS either directly through, for example, behavior treatment to address aggressive behavior, or through collaborating with other specialties treating PMS by combining, for example, behavioral principles in the alleviation of medical issues such as constipation. Currently, there is a role for the behavior analyst to expand our field and identify effective treatments for those with PMS while we wait for a cure. In this paper, we discuss how medical considerations may affect behavior interventions and make recommendations for the behavior analyst working with PMS.
费兰-麦克德米德综合征（PMS），也称为22q13.3缺失综合征，是一种罕见的遗传性疾病，全球至少影响2000人（费兰-麦克德米德综合征基金会，2019年，《费兰-麦克德米德综合征有多罕见？》）。PMS有许多显著特征，许多医学专科被推荐用于治疗其临床症状。虽然包括行为疗法在内的许多疗法被推测对治疗PMS有益，但关于它们的有效性知之甚少[科斯塔莱斯，J. L.和科列夫宗，A. 2015年。费兰-麦克德米德综合征与SHANK3：对治疗的启示。《神经治疗学：美国实验神经治疗学会杂志》，12，620 - 630。]。行为分析有能力在PMS治疗的许多领域提供帮助，要么直接通过例如行为治疗来解决攻击性行为，要么通过与治疗PMS的其他专科合作，例如将行为原则应用于缓解便秘等医疗问题。目前，在等待治愈方法的同时，行为分析师在拓展我们的领域并为PMS患者确定有效治疗方法方面发挥着作用。在本文中，我们讨论医学考量如何可能影响行为干预，并为与PMS患者合作的行为分析师提出建议。
